Shares on issue: 60,464,843
Share Price: $0.645
Market Cap: $39M
Pro forma net cash*: $27.1m
Enterprise Value: $11.9m
* Pro forma net cash is calculated as cash and cash equivalents as at 30 June 2021, plus gross Offer proceeds, less Offer costs, less net losses to mid September 2021. (As per the prospectus)
So the $11.9m valuation for a near Phase III chronic wound healing drug (TR-987).
SERIOUSLY!!!
Shares on issue: 60,464,843 Share Price: $0.645Market Cap:...
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TRP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.025(11.1%) |
Mkt cap ! $15.11M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 25.0¢ | $522 | 2.088K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12608 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 17703 | 2 |
View Market Depth
| Last trade - 10.24am 01/07/2024 (20 minute delay) ? |
| TRP (ASX) Chart |